NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders, including Haemophilia B
Estimated value
—
Awarded value
—
Suppliers
25
Lots
18
Published
04 Jul 2022
Description
National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B. The framework will commence on 1 July 2022 for a period of 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 moths. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for a list of the purchasing points.
Scope
- Reference
- CM/PHS/19/5576
- Commercial tool
- Standalone contract
- Contract dates
- 30 Jun 2022 to 30 Jun 2024
- Main category
- goods
- CPV classifications
- 33141530
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Security of Supply | 15% | quality | — |
| Ease of Use | 10% | quality | — |
| — | 75% | price | — |
| Ease of Use 10% | 10% | quality | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 25 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Lots · 18 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 18 | Lot 18 - Fresh Frozen Plasma | £1 | cancelled |
| 16 | Lot 16 - Prothrombin Complex dried | £1 | cancelled |
| 15 | Lot 15 - Fibrinogen Concentrate | £1 | cancelled |
| 14 | Lot 14 - Von willebrands factor - Recombinant | £1 | cancelled |
| 17 | Lot 17 - Protein C Concentrate | £1 | cancelled |
Award 1· 1 supplier
Awarded —
Award 2· 1 supplier
Awarded —
Award 3· 1 supplier
Awarded —
Award 4· 1 supplier
Awarded —
Award 5· 1 supplier
Awarded —
Award 6· 1 supplier
Awarded —
Award 7· 1 supplier
Awarded —
Award 8· 1 supplier
Awarded —
Award 9· 1 supplier
Awarded —
Award 10· 1 supplier
Awarded —
Award 11· 1 supplier
Awarded —
Award 12· 1 supplier
Awarded —
Award 13· 1 supplier
Awarded —
Award 14· 1 supplier
Awarded —
Award 15· 1 supplier
Awarded —
Award 16· 1 supplier
Awarded —
Award 17· 1 supplier
Awarded —
Award 18· 1 supplier
Awarded —
Award 19· 1 supplier
Awarded —
Award 20· 1 supplier
Awarded —
Award 21· 1 supplier
Awarded —
Award 22· 1 supplier
Awarded —
Award 23· 1 supplier
Awarded —
Award 24· 1 supplier
Awarded —
Award 25· 1 supplier
Awarded —
Total lots
18
Awarded
0
Estimated total
£18
Awarded total
—
Lot 18 - Fresh Frozen Plasma
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 16 - Prothrombin Complex dried
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 15 - Fibrinogen Concentrate
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 14 - Von willebrands factor - Recombinant
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 17 - Protein C Concentrate
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 10 - Factor XIII - Plasma Derived
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 11 - Factor XIII - Recombinant
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 9 - Factor X
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 8 - Factor IX - High Purity Factor IX
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 7 - Factor VIII Inhibitor Bypassing Fraction
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 13 - Von willebrands factor - Plasma Derived
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 12 - Factor VIII/ von willebrands factor
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 6 - Porcine Factor VIII - susoctocog alfa
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 5 - Recombinant Factor VII
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 4 - rFIX - Standard Half Life
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 3 - nonacog beta pegol (rFIX EHL)
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 2 - albutrepenonacog alfa (rFIX EHL)
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 1 - eftrenonacog alfa (rFIX EHL)
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Other contracts from NHS England
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Octapharma Limited· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Octapharma - Blood Disorder Treatment products (inc Haemophilia A & B) | contract | £72k | 12 Mar 2025 |
| NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin | contract | — | 20 Jan 2025 |
| Human Derived Blood Products | contract | — | 28 Aug 2024 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 | contract | — | 11 Jun 2024 |
| Octapharma Ltd - Octaplas LG | contract | £53k | 14 Jun 2023 |
| Octaplex Treatment | contract | £100k | 10 May 2023 |
| Blood product required for the treatment of TTP patients | contract | £98k | 03 Aug 2022 |
| Human Normal Immunoglobulin and Anti-D Immunoglobulin | contract | £64.3m | 23 Jul 2021 |
| NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin | contract | — | 22 Jul 2021 |
| NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga) | contract | — | 11 Jun 2021 |